Balchem Balance Sheet Health
Financial Health criteria checks 5/6
Balchem has a total shareholder equity of $1.1B and total debt of $266.6M, which brings its debt-to-equity ratio to 24%. Its total assets and total liabilities are $1.6B and $462.6M respectively. Balchem's EBIT is $161.0M making its interest coverage ratio 7.5. It has cash and short-term investments of $63.7M.
Key information
24.0%
Debt to equity ratio
US$266.57m
Debt
| Interest coverage ratio | 7.5x |
| Cash | US$63.74m |
| Equity | US$1.11b |
| Total liabilities | US$462.60m |
| Total assets | US$1.57b |
Recent financial health updates
Is Balchem (NASDAQ:BCPC) Using Too Much Debt?
Sep 09
These 4 Measures Indicate That Balchem (NASDAQ:BCPC) Is Using Debt Reasonably Well
Feb 18Balchem (NASDAQ:BCPC) Has A Pretty Healthy Balance Sheet
Oct 19Is Balchem (NASDAQ:BCPC) A Risky Investment?
Jul 19We Think Balchem (NASDAQ:BCPC) Can Stay On Top Of Its Debt
Mar 14Is Balchem (NASDAQ:BCPC) A Risky Investment?
Dec 13Recent updates
Is Balchem (NASDAQ:BCPC) Using Too Much Debt?
Sep 09Here's Why We Think Balchem (NASDAQ:BCPC) Might Deserve Your Attention Today
Aug 27Balchem Corporation's (NASDAQ:BCPC) Shares May Have Run Too Fast Too Soon
Aug 13Earnings Update: Here's Why Analysts Just Lifted Their Balchem Corporation (NASDAQ:BCPC) Price Target To US$184
Jul 31Return Trends At Balchem (NASDAQ:BCPC) Aren't Appealing
Jun 29Shareholders Will Most Likely Find Balchem Corporation's (NASDAQ:BCPC) CEO Compensation Acceptable
Jun 15Calculating The Intrinsic Value Of Balchem Corporation (NASDAQ:BCPC)
Jun 10Here's Why We Think Balchem (NASDAQ:BCPC) Is Well Worth Watching
May 26Balchem: A Tale Of Two Businesses
May 10Balchem Corporation's (NASDAQ:BCPC) Popularity With Investors Is Clear
Mar 21Is Balchem Corporation (NASDAQ:BCPC) Expensive For A Reason? A Look At Its Intrinsic Value
Mar 05Balchem: Potential Turnaround Is In The Price
Feb 21These 4 Measures Indicate That Balchem (NASDAQ:BCPC) Is Using Debt Reasonably Well
Feb 18Returns On Capital At Balchem (NASDAQ:BCPC) Have Stalled
Jan 03Balchem Corporation's (NASDAQ:BCPC) P/E Is On The Mark
Dec 19Estimating The Fair Value Of Balchem Corporation (NASDAQ:BCPC)
Nov 20Balchem (NASDAQ:BCPC) Has A Pretty Healthy Balance Sheet
Oct 19The Returns At Balchem (NASDAQ:BCPC) Aren't Growing
Sep 09A Look At The Intrinsic Value Of Balchem Corporation (NASDAQ:BCPC)
Aug 22Is Balchem (NASDAQ:BCPC) A Risky Investment?
Jul 19Some Investors May Be Worried About Balchem's (NASDAQ:BCPC) Returns On Capital
May 28Calculating The Fair Value Of Balchem Corporation (NASDAQ:BCPC)
May 12Do Balchem's (NASDAQ:BCPC) Earnings Warrant Your Attention?
Apr 12We Think Balchem (NASDAQ:BCPC) Can Stay On Top Of Its Debt
Mar 14Balchem (NASDAQ:BCPC) Hasn't Managed To Accelerate Its Returns
Jan 11Here's Why We Think Balchem (NASDAQ:BCPC) Is Well Worth Watching
Dec 29Is Balchem (NASDAQ:BCPC) A Risky Investment?
Dec 13Balchem Corporation (NASDAQ:BCPC) Shares Could Be 26% Above Their Intrinsic Value Estimate
Nov 29Here's What To Make Of Balchem's (NASDAQ:BCPC) Decelerating Rates Of Return
Sep 20Balchem: Acquisitions And Cost Pressures Draw Attention
Sep 12Balchem (NASDAQ:BCPC) Seems To Use Debt Rather Sparingly
Sep 05Balchem to acquire Cardinal Associates or Bergstrom Nutrition
Aug 30Is Balchem Corporation (NASDAQ:BCPC) Worth US$138 Based On Its Intrinsic Value?
Aug 22Should You Be Adding Balchem (NASDAQ:BCPC) To Your Watchlist Today?
Aug 08Balchem Q2 2022 Earnings Preview
Jul 28Balchem: On The M&A Road Again
Jun 28Balchem: A New Growth Stage Is Just Beginning
Jun 02Slowing Rates Of Return At Balchem (NASDAQ:BCPC) Leave Little Room For Excitement
May 30Balchem Corporation's (NASDAQ:BCPC) Intrinsic Value Is Potentially 17% Below Its Share Price
May 18Does Balchem (NASDAQ:BCPC) Deserve A Spot On Your Watchlist?
May 02Does Balchem (NASDAQ:BCPC) Have A Healthy Balance Sheet?
Mar 28Balchem (NASDAQ:BCPC) Hasn't Managed To Accelerate Its Returns
Feb 26Balchem (NASDAQ:BCPC) Could Easily Take On More Debt
Dec 23Return Trends At Balchem (NASDAQ:BCPC) Aren't Appealing
Nov 18Financial Position Analysis
Short Term Liabilities: BCPC's short term assets ($320.2M) exceed its short term liabilities ($113.3M).
Long Term Liabilities: BCPC's short term assets ($320.2M) do not cover its long term liabilities ($349.3M).
Debt to Equity History and Analysis
Debt Level: BCPC's net debt to equity ratio (18.2%) is considered satisfactory.
Reducing Debt: BCPC's debt to equity ratio has reduced from 31.4% to 24% over the past 5 years.
Debt Coverage: BCPC's debt is well covered by operating cash flow (72.1%).
Interest Coverage: BCPC's interest payments on its debt are well covered by EBIT (7.5x coverage).